There is an opportunity for biotech-style rewards hiding in an unexpected place: big pharma. Bristol-Myers Squibb and Celgene are set to close their $74 billion ...
Updated: 09/24/2019 04:23P
Real estate stocks quietly have been a leading sector this year, and three top ETFs currently offer investors ways to invest in this bullish trend.
Updated: 09/11/2019 03:00A